← FDA Drug Approvals (Drugs@FDA)

EMSAM

NDA · New Drug Application · Sponsor: SOMERSET · Approved 2006-02-27

Drug application

FDA Application #

NDA021336

Application type

New Drug Application

Brand name

EMSAM

Generic name

SELEGILINE

Active ingredients

SELEGILINE

Dosage form

FILM, EXTENDED RELEASE

Route

TRANSDERMAL

Marketing status

Prescription

Sponsor

SOMERSET

Manufacturer

Viatris Specialty LLC

First approval

2006-02-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown